Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: a project of Kyushu University Liver Disease Study (Q33788309)

29 July 2017

title

Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: a project of Kyushu University Liver Disease Study (English)

1 reference

29 July 2017

1 reference

1 reference

Norihiro Furusyo

1

1 reference

29 July 2017

Hiroaki Takeoka

2

1 reference

29 July 2017

Kazuhiro Toyoda

3

1 reference

29 July 2017

Masayuki Murata

4

1 reference

29 July 2017

Yuichi Tanabe

5

1 reference

29 July 2017

Eiji Kajiwara

6

1 reference

29 July 2017

Junya Shimono

7

1 reference

29 July 2017

Akihide Masumoto

8

1 reference

29 July 2017

Toshihiro Maruyama

9

1 reference

29 July 2017

Hideyuki Nomura

10

1 reference

29 July 2017

Makoto Nakamuta

11

1 reference

29 July 2017

Kazuhiro Takahashi

12

1 reference

29 July 2017

Shinji Shimoda

13

1 reference

29 July 2017

Koichi Azuma

14

1 reference

29 July 2017

Hironori Sakai

15

1 reference

29 July 2017

Jun Hayashi

16

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

World Journal of Gastroenterology

29 July 2017

published in

1 reference

29 July 2017

volume

12

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

561-567

1 reference

Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Prevention of hepatitis B virus-related hepatocellular carcinoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Relationship of genotype rather than race to hepatitis B virus pathogenicity: a study of Japanese and Solomon Islanders

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Management of hepatitis B: 2000--summary of a workshop

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: a prospective, long-term, follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

The treatment of chronic viral hepatitis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.

4 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I4.561

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I4.561

Long-term lamivudine therapy for chronic hepatitis B in patients with and without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I4.561

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I4.561

Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I4.561

Double point mutation in the core promoter region of hepatitis B virus (HBV) genotype C may be related to liver deterioration in patients with chronic HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I4.561

Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I4.561

Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I4.561

Clinical outcomes of hepatitis B virus (HBV) genotypes B and C in Japanese patients with chronic HBV infection

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066088

30 October 2018

1 reference

12 December 2020

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

12 December 2020

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

12 December 2020

Lamivudine resistance inimmunocompetent chronic hepatitis B

1 reference

12 December 2020

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I4.561

1 reference

29 July 2017

1 reference

29 July 2017

1 reference